Monday, June 08, 2020 7:34:13 AM
Recent CTSO News
- Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 01/07/2025 06:26:16 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/06/2025 09:31:41 PM
- CytoSorbents Expands Global Footprint with Opening of New Regional Sales Subsidiary in Dubai • GlobeNewswire Inc. • 01/06/2025 12:00:00 PM
- CytoSorbents Reports Preliminary Unaudited Fourth Quarter and Full-Year 2024 Product Revenue • GlobeNewswire Inc. • 01/03/2025 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/23/2024 09:05:10 PM
- CytoSorbents Rights Offering Begins • GlobeNewswire Inc. • 12/23/2024 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/16/2024 12:00:11 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/13/2024 01:00:13 PM
- CytoSorbents to Host Investor Meetings in San Francisco During J.P. Morgan Healthcare Conference Week • GlobeNewswire Inc. • 12/12/2024 12:00:00 PM
- Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses • Edgar (US Regulatory) • 12/09/2024 12:18:15 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 12/09/2024 12:17:32 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/09/2024 12:08:06 PM
- CytoSorbents Announces Rights Offering • GlobeNewswire Inc. • 12/09/2024 12:00:00 PM
- CytoSorbents to Participate at the Piper Sandler 36th Annual Healthcare Conference • GlobeNewswire Inc. • 11/26/2024 12:00:00 PM
- CytoSorbents And Converge Biotech Announce Strategic Partnership to Expand Sepsis and Critical Care Treatment with CytoSorb in India • GlobeNewswire Inc. • 11/11/2024 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/07/2024 09:10:58 PM
- CytoSorbents Reports Third Quarter 2024 Financial and Operational Results • GlobeNewswire Inc. • 11/07/2024 09:05:00 PM
- CytoSorbents Submits Health Canada Medical Device License Application for DrugSorb-ATR Following MDSAP Certification • GlobeNewswire Inc. • 11/04/2024 12:00:00 PM
- FDA Accepts DrugSorb-ATR De Novo Application To Reduce the Severity of CABG-Related Bleeding Due to Ticagrelor and Initiates Substantive Review • GlobeNewswire Inc. • 10/22/2024 11:00:00 AM
- CytoSorbents to Report Third Quarter 2024 Operating and Financial Results • GlobeNewswire Inc. • 10/17/2024 11:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/09/2024 01:00:46 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/09/2024 01:00:14 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/01/2024 09:25:15 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 10/01/2024 09:22:32 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/01/2024 12:06:10 PM
FEATURED Cannabix Technologies Announces Key Hardware Advancements to Marijuana Breathalyzer Technology • Jan 9, 2025 8:49 AM
UAV Corp. (UMAV) Further Reduces Authorized Shares to 500 Million • UMAV • Jan 8, 2025 2:27 PM
Fifty 1 Labs, Inc. Launches Dedicated Website for Shareholders and Investors, Company now current with OTC Markets • CAFI • Jan 7, 2025 9:00 AM
EzFill Holdings, Inc. Successfully Closes Acquisition of Shell Fleet, Accelerating Nationwide Mobile Fueling Expansion • EZFL • Jan 7, 2025 8:35 AM
CGRA Signs Binding Term Sheet to Merge With American Infrastructure Corporation, a Subsidiary of Nasdaq-listed American Resources Corporation (Nasdaq: AREC) • CGRA • Jan 6, 2025 10:31 AM
UAV Corp (UMAV) Working on Securing $1.5 Billion in Contracts and Announces Groundbreaking Partnership with Atlantic Industrial Group • UMAV • Jan 6, 2025 9:26 AM